Sulfadoxine–pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire

References

• Basco, L. K., Ramiliarisoa, O. & Le Bras, J. (1994). In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 50,193–199.
   PubMed Web of Science ®Google Scholar
• Basco, L. K., Eldin de Pecoulas, P., Wilson, C. M., Le Bras, J. & Mazabraud, A. (1995). Point mutations in the dihydrofolate reductase—thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology, 69, 135-138.
   Google Scholar
• Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G. & Hyde, J. E. (1994). Sequence variation of hydroxymethyldihydroprotein pyropho-sphokinase: dihydropteroate synthetase gene in lines of the human malaria parasites, Plasmodium falci-parum, with differing resistance to sulfadoxine. European Journal of Biochemistry, 224,397–405.
   PubMedGoogle Scholar
• Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37–46.
   Web of Science ®Google Scholar
• Desjardins, R. E., Canfields, C. J., Haynes, J. P. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710–718.
   PubMed Web of Science ®Google Scholar
• Djaman, J. A., Basco, L. K. & Mazabraud, A. (2002). Mise en place d'un systeme de surveillance de la chimioresistance de Plasmodium falciparum Yopougon (Abidjan): etude in vivo de la sensibilite a la chloroquine et evaluation de la resistance a la pyrimethamine apres analyse de la mutation ponc-tuelle du gene de la dihydrofolate reductase. Santé, 12, 363–367.
   PubMedGoogle Scholar
• Djaman, J. A., Abouanou, S., Basco, L. & Kone, M. (2004a). Limites de l'efficacite de la chloroquine et de la sulfadoxine—pyrimethamine au nord de la ville d'Abidjan (Cote d'Ivoire): etude couplee in vivo/in vitro. Santé, 14, 205–209.
   Google Scholar
• Djaman, J. A., Kauffi, P. C., Yavo, W., Basco, L. K. & Kone, M. (2004b). Evaluation in vivo de l'efficacite therapeutique de l'association sulfadoxine—pyri-methamine au cours du paludisme non complique chez les enfants de Yopougon (Abidjan, 0:Re d'Ivoire). Bulletin de la Société de Pathologie Exotigue, 97, 180–182.
   PubMedGoogle Scholar
• Dorsey, G., Njama, D., Kamya, M. R., Cattamanchi, A., Kyabayinze, D., Staedke, S. G., Gasasira, A. & Rosenthal, P. J. (2002). Sulfadoxine/ pyrimethamine alone or with amodiaquine or arte-sunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet, 360, 2031–2038.
   PubMed Web of Science ®Google Scholar
• Eldin de Pecoulas, P., Basco, L. K., Abdallah, B., Dje, M. K., Le Bras, J. & Mazabraud, A. (1995). Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Experimental Parasitology, 80, 483-487.
   Google Scholar
• Fermanian, J. (1984). Mesure de l'accord entre deux juges. Gas qualitatif. Revue Epidémiologique et Santé Publique, 32, 140–147.
   PubMed Web of Science ®Google Scholar
• Foote, S. J., Galatas, D. & Cowman, A. F. (1990). Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the United States of America, 87, 3014–3017.
   PubMed Web of Science ®Google Scholar
• Guiguemde, T. R., Gbary, A. R., Ouedraogo, J. B., Gayibor, A., Larnizana, L., Maiga, A. S., Boureima, H. S., Comlavi, C. E., Faye, O. & Niang, S. O. (1991). Point actuel sur la chimiorésistance du paludisme des sujets autochtones dans les etats de l'OCCGE (Afrique de l'Ouest). Annales de la Société Belge de Medécine Tropicale, 71, 199–207.
   PubMedGoogle Scholar
• Henry, M. C., Niangue, J. & Koné, M. (2002). Quel médicarnent pour traiter le paludisme simple quand la chloroquine devient inefficace dans l'ouest de la Cote d'Ivoire? Médecine Tropicale, 62, 55–57.
   PubMedGoogle Scholar
• Hyde, J. E. (1990). The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacology and Therapeutics, 48, 45–59.
   PubMed Web of Science ®Google Scholar
• Hyde, J. E. (2002). Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection, 4, 165–174.
   PubMed Web of Science ®Google Scholar
• Kamya, M. R., Dorsey, G., Gasasira, A., Ndeezi, G., Babirye, J. N., Staedke, S. G. & Rosenthal, P. J. (2001). The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 50–55.
   PubMed Web of Science ®Google Scholar
• Masimirembwa, C. M., Phuong Dung, N., Phuc, B. Q., Duc Dao, L., Sy, N. D., Skold, O. & Swedberg, G. (1999). Molecular epidemiology of Plasmodium falciparum antifolate resistance in Viemam: genotyp-ing for resistance variants of dihydropteroate synthase and dihydrofolate reductase. International Journal of Antimicrobial Agents, 12, 203–211.
   PubMed Web of Science ®Google Scholar
• Mberu, E. K., Nzila, A. M., Nduati, E., Ross, A., Monks, S. M., Kokwaro, G. O., Watkins, W. M. & Sibley, C. (2002). Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Experimental Parasitology, 101, 90–96.
   PubMed Web of Science ®Google Scholar
• Peterson, D. S., Walliker, D. & Wellems, T. E. (1988). Evidence that a point mutation in the dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 85, 9114–9118.
   PubMed Web of Science ®Google Scholar
• Peterson, D. S., Milhous, W. K. & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falci-parum malaria. Proceedings of the National Academy of Sciences of the United States of America, 87, 3018–3022.
   PubMed Web of Science ®Google Scholar
• Ringwald, P., Keundjian, A., Same Ekobo, A. & Basco, L.K. (2000). Chimiorésistance de P. falciparum en milieu urbain a Yaoundé, Cameroun. Part 2: Evaluation de l'efficacite de l'amodiaquine et de l'association sulfadoxine-pyrimethamine pour le trai-tement de l'accès palustre simple a Plasmodium falciparum a Yaoundé, Cameroun. Tropical Medicine and International Health, 5, 620–627.
   PubMedGoogle Scholar
• Triglia, T., Menting, J. G. T., Wilson, C. & Cowman, A. F. (1997). Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resis-tance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America, 94, 13,944-13,949.
   Google Scholar
• Wang, P., Lee, C. S., Bayoumi, R., Djimde, A., Doumbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., Sims, P. F. & Hyde, J. E. (1997a). Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydro-folate reductase alleles in a large number of field samples of diverse origins. Molecular and Biochemical Parasitology, 89, 161-167.
   Google Scholar
• Wang, P., Sims, P. F. & Hyde J. E. (1997b). A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance. Parasitology, 115, 223–230.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1996). Assessment of Therapeutic Efficacy for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL96. 1077. Geneva: WHO.
   Google Scholar
• World Health Organization (2003). Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Document WHO/HTM/RBM/2003.50. Geneva: WHO.
   Google Scholar